Introduction of Ceftolozane/Tazobactam Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 6 Code History

Introduction of Obecabtagene Autoleucel into Central Vein, Percutaneous Approach, New Technology Group 10 Code History

Introduction of Treosulfan into Central Vein, Percutaneous Approach, New Technology Group 8 Code History

Introduction of Lurbinectedin into Central Vein, Percutaneous Approach, New Technology Group 7 Code History

Introduction of Tabelecleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 8 Code History

Introduction of Trilaciclib into Central Vein, Percutaneous Approach, New Technology Group 7 Code History

Introduction of Inactivated Coagulation Factor Xa into Central Vein, Percutaneous Approach, New Technology Group 2 Code History

Introduction of Afamitresgene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 8 Code History

Introduction of Terlipressin into Central Vein, Percutaneous Approach, New Technology Group 7 Code History

Introduction of Lefamulin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 6 Code History